We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ST icon
976
Sensata Technologies
ST
$6.79B
$297K ﹤0.01%
6,068
+4,368
+257% +$208K
HFWA icon
977
Heritage Financial
HFWA
$1.21B
$296K ﹤0.01%
+10,010
New +$301K
BHE icon
978
Benchmark Electronics
BHE
$2.96B
$295K ﹤0.01%
11,742
+11,042
+1,577% +$284K
LORL
979
DELISTED
Loral Space and Communications, Inc.
LORL
$293K ﹤0.01%
+8,492
New +$307K
GSKY
980
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$287K ﹤0.01%
23,332
-93,305
-80% -$1.22M
VIAV icon
981
Viavi Solutions
VIAV
$9.66B
$285K ﹤0.01%
+21,432
New +$277K
MGP
982
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$285K ﹤0.01%
9,293
-57,934
-86% -$1.84M
NIHD
983
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$285K ﹤0.01%
168,380
-224,734
-57% -$428K
LEVI icon
984
Levi Strauss
LEVI
$9.39B
$281K ﹤0.01%
13,497
-98,243
-88% -$2.16M
EZPW icon
985
Ezcorp Inc
EZPW
$1.71B
$279K ﹤0.01%
+29,473
New +$287K
CHH icon
986
Choice Hotels
CHH
$4.8B
$277K ﹤0.01%
+3,178
New +$265K
PRLB icon
987
Protolabs
PRLB
$2.13B
$277K ﹤0.01%
+2,390
New +$257K
WTRE
988
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$276K ﹤0.01%
+10,040
New +$266K
SSP icon
989
E.W. Scripps
SSP
$304M
$274K ﹤0.01%
+17,948
New +$336K
ZYME icon
990
Zymeworks
ZYME
$1.67B
$274K ﹤0.01%
+12,438
New +$228K
AXON
991
Axon Enterprise
AXON
$46.4B
$272K ﹤0.01%
+4,237
New +$276K
SVM
992
Silvercorp Metals
SVM
$2.53B
$269K ﹤0.01%
108,600
-63,800
-37% -$146K
BALL icon
993
Ball Corp
BALL
$16.8B
$266K ﹤0.01%
3,800
-400
-10% -$24.8K
DAR icon
994
Darling Ingredients
DAR
$9.44B
$266K ﹤0.01%
13,397
-34,079
-72% -$699K
NOA
995
North American Construction
NOA
$395M
$263K ﹤0.01%
+24,335
New +$283K
NBLX
996
DELISTED
Noble Midstream Partners LP
NBLX
$261K ﹤0.01%
7,825
-4,166
-35% -$141K
LL
997
DELISTED
LL Flooring Holdings, Inc.
LL
$259K ﹤0.01%
22,399
+994
+5% +$11.2K
MCFT icon
998
MasterCraft Boat Holdings
MCFT
$590M
$258K ﹤0.01%
+13,178
New +$300K
INST
999
DELISTED
Instructure, Inc.
INST
$258K ﹤0.01%
+6,063
New +$262K
ALLO icon
1000
Allogene Therapeutics
ALLO
$694M
$256K ﹤0.01%
9,531
-230,529
-96% -$6.42M
38 39
40
41 42

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.